Sagimet Biosciences (SGMT) Institutional Ownership $4.65 +0.13 (+2.88%) (As of 09:15 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Sagimet Biosciences (NASDAQ:SGMT)CurrentInstitutional OwnershipPercentage87.86%Number ofInstitutional Buyers(last 12 months)16TotalInstitutional Inflows(last 12 months)$9.06MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$18.85M Get SGMT Insider Trade Alerts Want to know when executives and insiders are buying or selling Sagimet Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SGMT Institutional Buying and Selling by Quarter Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Sagimet Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/20/2024Virtu Financial LLC34,166$95K0.0%-34.1%0.111% 11/19/2024 Barclays PLC57,230$159K0.0%+14.3%0.187% 11/16/2024 Geode Capital Management LLC252,298$699K0.0%+56.7%0.823% 11/15/2024 Barclays PLC57,230$159K0.0%+14.3%0.187% 11/15/2024 Ikarian Capital LLC387,565$1.07M0.1%-6.1%1.264% 10/11/2024 ORG Wealth Partners LLC42,896$119K0.0%N/A0.140% Get the Latest News and Ratings for SGMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sagimet Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/19/2024 Point72 Asset Management L.P.2,366,090$8.09M0.0%-11.3%7.786% 8/14/2024 Squarepoint Ops LLC94,740$324K0.0%N/A0.312% 8/12/2024 XTX Topco Ltd41,548$142K0.0%-29.8%0.137% 8/9/2024 Renaissance Technologies LLC242,400$829K0.0%-42.2%0.798% 8/8/2024 Federated Hermes Inc.68,000$233K0.0%+25.9%0.224% 8/8/2024 Ground Swell Capital LLC22,687$78K0.1%N/A0.075% 8/6/2024 Acadian Asset Management LLC68,451$232K0.0%+96.0%0.225% 8/5/2024 Victory Capital Management Inc.77,420$265K0.0%+49.1%0.255% 7/29/2024 Nations Financial Group Inc. IA ADV15,000$51K0.0%N/A0.049% 7/16/2024 ORG Partners LLC13,611$43K0.0%N/A0.045% 6/4/2024 DekaBank Deutsche Girozentrale20,000$113K0.0%N/A0.066% 5/17/2024 Artal Group S.A.724,771$3.93M0.1%-21.6%2.271% 5/17/2024 Ikarian Capital LLC412,565$2.24M0.2%N/A1.293% 5/15/2024 Baker BROS. Advisors LP1,381,898$7.49M0.1%-5.1%4.331% 5/15/2024 NEA Management Company LLC2,000,275$10.84M0.7%-48.0%6.268% 5/15/2024 Price T Rowe Associates Inc. MD16,705$91K0.0%N/A0.052% 5/15/2024 Hhlr Advisors LTD.724,800$3.93M0.1%-50.0%2.271% 5/14/2024 Platinum Investment Management Ltd.90,633$491K0.0%-18.9%0.284% 5/14/2024 American International Group Inc.11,372$62K0.0%+312.0%0.036% 5/13/2024 O Shaughnessy Asset Management LLC13,344$72K0.0%N/A0.042% 5/10/2024 Acadian Asset Management LLC34,929$188K0.0%N/A0.109% 5/10/2024 Vanguard Group Inc.1,139,407$6.18M0.0%+364.9%3.570% 2/14/2024 Platinum Investment Management Ltd.111,752$606K0.0%-70.9%0.523% 2/5/2024 Victory Capital Management Inc.56,570$307K0.0%+215.0%0.265% 1/31/2024 Federated Hermes Inc.97,276$527K0.0%+24.7%0.455% 11/15/2023 RTW Investments LP400,277$3.52M0.1%N/A1.875% 11/15/2023 Rock Springs Capital Management LP738,355$6.50M0.2%N/A3.458% 11/14/2023 Dumac Inc.204,123$1.80M4.8%N/A0.956% 11/13/2023CHI Advisors LLC348,842$3.07M0.9%N/A1.634% 11/13/2023 Federated Hermes Inc.78,000$686K0.0%N/A0.365% 11/13/2023 Silverarc Capital Management LLC100,000$880K0.3%N/A0.468% 11/13/2023 FMR LLC2,672,355$23.52M0.0%N/A12.517% 11/7/2023 New York State Common Retirement Fund6,357$56K0.0%N/A0.030% 11/6/2023 Victory Capital Management Inc.17,960$158K0.0%N/A0.084% JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late.11/3/2023 Platinum Investment Management Ltd.383,913$3.38M0.1%N/A1.798% 10/31/2023 Teacher Retirement System of Texas25,000$220K0.0%N/A0.117% (Data available from 1/1/2016 forward) SGMT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SGMT shares? During the previous two years, 33 institutional investors and hedge funds held shares of Sagimet Biosciences. The most heavily invested institutionals were FMR LLC ($23.52M), NEA Management Company LLC ($10.84M), Point72 Asset Management L.P. ($8.09M), Baker BROS. Advisors LP ($7.49M), Rock Springs Capital Management LP ($6.50M), Vanguard Group Inc. ($6.18M), and Artal Group S.A. ($3.93M).Learn more on SGMT's institutional investors. What percentage of Sagimet Biosciences stock is owned by institutional investors? 87.86% of Sagimet Biosciences stock is owned by institutional investors. Learn more on SGMT's institutional investor holdings. Which institutional investors have been buying Sagimet Biosciences stock? Of the 25 institutional investors that purchased Sagimet Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.67M), Vanguard Group Inc. ($894.32K), Rock Springs Capital Management LP ($738.36K), Ikarian Capital LLC ($412.57K), RTW Investments LP ($400.28K), Platinum Investment Management Ltd. ($383.91K), and CHI Advisors LLC ($348.84K). How much institutional buying is happening at Sagimet Biosciences? Institutional investors have bought a total of 6,801,080 shares in the last 24 months. This purchase volume represents approximately $52.85M in transactions. Which Sagimet Biosciences major shareholders have been selling company stock? Of the 10 institutional investors that sold Sagimet Biosciences stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: NEA Management Company LLC ($1.85M), Hhlr Advisors LTD. ($724.74K), Point72 Asset Management L.P. ($300.69K), Platinum Investment Management Ltd. ($293.28K), Artal Group S.A. ($200K), Renaissance Technologies LLC ($177K), and Baker BROS. Advisors LP ($74.62K). How much institutional selling is happening at Sagimet Biosciences? Institutional investors have sold a total of 3,680,629 shares in the last 24 months. This volume of shares sold represents approximately $18.85M in transactions. Related Companies Sana Biotechnology Institutional Ownership ABIVAX Société Anonyme Institutional Ownership Astria Therapeutics Institutional Ownership Annexon Institutional Ownership Corvus Pharmaceuticals Institutional Ownership Organogenesis Institutional Ownership PureTech Health Institutional Ownership Mereo BioPharma Group Institutional Ownership Monte Rosa Therapeutics Institutional Ownership GH Research Institutional Ownership This page (NASDAQ:SGMT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sagimet Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
